Fig. 4From: A novel prostaglandin I2 agonist, ONO-1301, attenuates liver inflammation and suppresses fibrosis in non-alcoholic steatohepatitis model miceEffects of ONO-1301 against macrophages in vitro. A Schematic of the experiment. B After addition of lipopolysaccharide (25 ng/ml), ONO-1301 (0.01 μM) to macrophage cultures, mRNA expression levels of Il6, Ccl2, Tnfa, Inos, Il10, and Cd206 were analyzed (each experiment was repeated seven times). C cAMP levels of each condition were analyzed of three independent experiments. Data are presented as mean ± standard deviation. ns: not significantBack to article page